Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Clinical trial NCT00428922 · COMPLETED
Trial details
- NCT number
- NCT00428922
- Sponsor
- Bhuvaneswari Ramaswamy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-14
- Primary completion
- 2012-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.